Brick & Kyle Associates’s Elevance Health ELV Stock Holding History

Brick & Kyle Associates’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,450	Closed	-$4.78M	–	60
2021 Q1	$4.78M	Buy	13,450 +341	+3%	+$110K	2.64%	13
2020 Q4	$4.2M	Sell	13,109 -66	-0.5%	-$20.3K	2.62%	17
2020 Q3	$3.52M	Buy	+13,175	New	+$3.54M	2.43%	17
2017 Q2	–	Sell	-100	Closed	-$17K	–	169
2017 Q1	$17K	Hold	100	–	–	0.01%	297
2016 Q4	$14K	Hold	100	–	–	0.01%	319
2016 Q3	$13K	Hold	100	–	–	0.01%	321
2016 Q2	$13K	Hold	100	–	–	0.01%	317
2016 Q1	$14K	Hold	100	–	–	0.01%	303
2015 Q4	$14K	Hold	100	–	–	0.01%	301
2015 Q3	$14K	Hold	100	–	–	0.01%	301
2015 Q2	$16K	Hold	100	–	–	0.01%	310
2015 Q1	$15K	Hold	100	–	–	0.01%	318
2014 Q4	$13K	Buy	+100	New	+$12.4K	0.01%	323

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brick & Kyle Associates's ELV Position: Q2 2021 in Review

Brick & Kyle Associates sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 13,450 shares — an estimated $4.78M sold.

Brick & Kyle Associates first reported a position in ELV in Q4 2014 and held it in 13 quarters. The position peaked at $4.78M in Q1 2021. 1,238 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

Brick & Kyle Associates reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
Brick & Kyle Associates sold 13,450 Elevance Health shares in Q2 2021, an estimated $4.78M.
Brick & Kyle Associates first reported a position in Elevance Health in Q4 2014 and held it in 13 quarters.
Brick & Kyle Associates's Elevance Health position peaked at $4.78M in Q1 2021.
1,238 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Brick & Kyle Associates's 13F filing for Q2 2021, filed 18 Aug 2021.